KFH selects Codebase Technologies to forefront its RegTech platform ibsintelligence.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibsintelligence.com Daily Mail and Mail on Sunday newspapers.
Kuwait Finance House selects Codebase Technologies to expand the bank s digital reach ibsintelligence.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibsintelligence.com Daily Mail and Mail on Sunday newspapers.
Kuwait Finance House-Bahrain launches the first automated reporting platform
Kuwait Finance House (KFH) – Bahrain, one of the leading Islamic banks and an integral contributor to the evolution of Bahrain’s Islamic Financial sector, has announced signing a strategic partnership with Codebase Technologies (CBT), a leading global Open API banking solutions provider, to further expand the Bank’s digitization and automation needs with the implementation of Digibanc™ RegReporting, Bahrain’s first automated reporting platform. The partnership aims to enhance regulatory transparency and streamline compliance operations.
The new technology aims to support financial institutions in carrying out internal processes, in light of the changes witnessed due to the integration of technology in the banking and finance fields, directed by the Central Bank regulations. KFH-Bahrain sought the banking solutions provider’s expertise in establishing an automated, flexible platform for regulato
(0) Tubulis today announced the appointment of Günter Fingerle-Rowson, MD, PhD, as Chief Medical Officer to complement the leadership team and to further build the company s clinical expertise. Dr. Fingerle-Rowson is an experienced hematologist and medical oncologist who brings to Tubulis more than two decades of academic, biotechnology and pharmaceutical industry experience. Moreover, he has a proven track record of advancing product candidates from early clinical phase through regulatory approval and into clinical practice. In this newly established role, he will use his extensive knowledge in the development of cancer therapeutics to oversee Tubulis clinical activities and advance the company s Antibody Drug Conjugates (ADCs) towards clinical evaluation.